Podcasts about improving care

In this episode, we sit down with NCQA leaders Stacy Grundy, Rachel Harrington and Kristine Toppe for a behind-the-scenes look at the upcoming Health Quality Forum 2025, and a discussion about the complexities and possibilities of modern health care, with a focus on data sharing and strategies to address health inequities.Learn about data-driven collaborations in states like Maryland, Pennsylvania and North Carolina, where public agencies, health systems and community groups are uniting to improve outcomes.And get an inside look at our hands-on workshops on NCQA Health Equity Accreditation and Virtual Care Accreditation, designed to give professionals at the leading edge of virtual services the tools they need to help reduce disparities.The conversation and conference highlight stories of how virtual care is dissolving data silos and transforming maternal health in states like Arkansas. The emphasis of this episode—and the forum—is on curating diverse voices not often featured at national meetings. The common thread: Moving beyond identifying problems to showcase solutions that work.Key Quote:“ Data for the sake of data doesn't help anybody. If it just sits there and you pat yourself on the back, ‘I've got this sitting in my database';  that doesn't help.  What you do with it, matters.We have a couple of sessions  digging into  innovating to address health disparities, talking about  analytics  to understand  populations and how to address interventions. Also, we have  sessions  focused on creating equitable systems of care for populations with disabilities.Understanding where  unmet needs are, how to  make things accessible, make things usable—data is part of that. It's understanding who, what, when, where and how to take what you're sitting on in your organization and understand it  so you can improve care.” Rachel HarringtonTime Stamps:(00:43) What's Different About the Health Quality Forum(03:40) An Expanded, Regional Lens on Quality (6:09) How NCQA Sees Data and Interoperability Differently (10:38) Improving Care in Rural Areas (16:04)  How-to Workshops on NCQA Accreditation(17:55) Personal Highlights at the Forum Links:Register for the 2025 NCQA Health ForumConnect with Stacy GrundyConnect with Rachel HarringtonConnect with Kristine Toppe

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002047. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Standards of Care in Diabetes-2025 https://diabetesjournals.org/care/issue/48/Supplement_1 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025 https://pubmed.ncbi.nlm.nih.gov/39651988/ 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025 https://pubmed.ncbi.nlm.nih.gov/39651976/ The Simplified Nutritional Appetite Questionnaire (SNAQ) as a Screening Tool for Risk of Malnutrition: Optimal Cutoff, Factor Structure, and Validation in Healthy Community-Dwelling Older Adults https://pubmed.ncbi.nlm.nih.gov/32967354/ Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension https://pubmed.ncbi.nlm.nih.gov/35441470/ 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025 https://pubmed.ncbi.nlm.nih.gov/39651989/ 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025 https://pubmed.ncbi.nlm.nih.gov/39651974/

In this episode, Sowmya Viswanathan, MD, MHCH, MBA, FACP, Chief Physician Executive of BayCare Health System shares her healthcare journey and insights on the evolving role of physician executives in health systems.  Dr. Viswanathan discusses BayCare's digital initiatives, including EMRs, telehealth, RPM, AI, data platforms, interoperability, and cybersecurity. She also explores the impact of AI in healthcare, particularly in assisting doctors and nurses with patient interactions – ensuring that key details from conversations are captured accurately. She expresses her fascination with AI and Generative AI and their ability to aggregate and utilize data effectively to enhance patient care. While AI represents the next generation of transformation, Dr. Viswanathan stresses the need for responsible adoption to mitigate risks and build trust. She believes AI-driven tools, like ChatGPT, has the ability to support clinicians and drive better patient outcomes. She also states that as healthcare embraces technology and as AI proves its value in improving care delivery, widespread adoption will come. Take a listen.

Roz Benson (digital learning editor) talks to consultant rheumatologist Dr Lizzy MacPhie and Resident doctor Nouran Abdou about a recent project digging deep into the reasons prisoners face difficulty in accessing care in the rheumatology clinic. This excellent project showcases how quality improvement can be a tool in helping to approach and reduce health inequalities.The countdown to #BSR25 begins!Our full Annual Conference 2025 programme is now available. Browse 100+ sessions and get ready for an inspiring event. https://bit.ly/4bGFX1NThanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK.BSR is the UK's leading specialist medical society for rheumatology and MSK health professionals. To discover how we can support you in delivering the best care for your patients, visit our website.

On Good Tech, our weekly segment spotlighting technology that drives meaningful social change, we explore how innovation is transforming maternal healthcare. Millions of expectant mothers still face complications that could result in mortality due to gaps in accessibility. But, what if technology could bridge that divide? Singapore-based MedTech startup Biorithm is leading the way with Femom, a remote monitoring platform that empowers clinicians with real-time data and improving access to maternal care. Amrish Nair, Co-founder and Chief Technology Officer of Biorithm, to discuss how his team is redefining maternal care to prevent complications before they arise.See omnystudio.com/listener for privacy information.

BioIntelliSense is revolutionizing remote patient monitoring through their medical-grade BioButton® wearable device, delivering continuous vital sign trending and AI-powered clinical intelligence for both hospital and home care settings.

Send us a textWelcome to the debut episode of Rupa's Fellows Friday, a new series on The Incubator podcast, hosted by Dr. Srirupa Gopal. This series celebrates the incredible research and passion of neonatology fellows from around the globe. Our first guest, Dr. Amee Amin, a third-year neonatology fellow at Texas Children's Hospital (TCH), shares her inspiring journey and groundbreaking work in global health.Dr. Amin discusses her diverse background—born in Kenya, raised in Tanzania, and trained in India, the UK, and the US—and how it shaped her dedication to improving neonatal care in low-resource settings. She highlights her recent project: developing and implementing a low-cost continuous respiratory rate monitor designed for use in neonatal intensive care units in low- and middle-income countries. This innovative device, created in collaboration with Rice University, uses sensors to measure respiratory rates accurately and affordably, empowering healthcare providers with vital tools in resource-constrained settings.The conversation also delves into the challenges of conducting global health research during fellowship, the importance of mentorship, and Dr. Amin's transformative experiences working in Malawi and presenting at the Tiny Feet Big Steps conference in Tanzania. This inspiring episode highlights the power of passion, collaboration, and innovation in neonatology. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Rachel Goodwin, MD, MSc, FRCPC - Improving Care for Advanced Colorectal Cancer With Later-Line Treatments

In this episode of the AHP QI Podcast, we're joined by Ceara Gallagher (AHP Consultant) to explore the journey of developing an effective falls pathway in care homes. Ceara shares her expertise in tackling one of the most significant challenges in healthcare: reducing the risk of falls and improving post fall care. From identifying key gaps in care to implementing innovative solutions, Ceara discusses the collaborative approach that brought this pathway to life. Listeners will gain insights into the importance of quality improvement in allied health and learn practical strategies for addressing falls prevention in their own practice. This episode is a must-listen for anyone passionate about creating safer, more effective care pathways. Project InformationEnhancing Clinical Care Framework (ECCF) in Northern Ireland Care Homes | Department of Health (health-ni.gov.uk) Regional Falls in Care Homes Pathway and Bundle | Department of Health (health-ni.gov.uk)   Other resources GREAT resources - HSCQI (hscni.net) Staff and service user guidance on co production Personal & Public Involvement (PPI) – Involving You, Improving Care (hscni.net) PHA PPI website https://youtu.be/a-_6UWwHdCk Service user reflective interview on being involved in a project Events Shine a light on co-production https://future.nhs.uk/AlwaysEvents/view?objectID=29393264 Music: "Rising Tide" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 Licensehttp://creativecommons.org/licenses/by/4.0/

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/MOC information, and to apply for credit, please visit us at PeerView.com/QQD865. CME/EBAC/MOC credit will be available until December 13, 2025.Improving Care for Pediatric and Adult Patients With Eosinophilic Esophagitis: Expert Insights on the Latest Evidence for Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/MOC information, and to apply for credit, please visit us at PeerView.com/QQD865. CME/EBAC/MOC credit will be available until December 13, 2025.Improving Care for Pediatric and Adult Patients With Eosinophilic Esophagitis: Expert Insights on the Latest Evidence for Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/MOC information, and to apply for credit, please visit us at PeerView.com/QQD865. CME/EBAC/MOC credit will be available until December 13, 2025.Improving Care for Pediatric and Adult Patients With Eosinophilic Esophagitis: Expert Insights on the Latest Evidence for Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/MOC information, and to apply for credit, please visit us at PeerView.com/QQD865. CME/EBAC/MOC credit will be available until December 13, 2025.Improving Care for Pediatric and Adult Patients With Eosinophilic Esophagitis: Expert Insights on the Latest Evidence for Targeted Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure information is available at the beginning of the video presentation.

This week's podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from... The post Improving care for patients with SCD: pain management, ongoing projects & unmet needs appeared first on VJHemOnc.

The latest episode of Digital Health Unplugged explores how data and digital solutions are improving care pathways and advancing clinical research. Brought to you in partnership with Oracle Health, Jordan Sollof passes the hosting duties over to Ryan Irwin, lead client executive at Oracle Health. He is joined by Ameet Bakhai, consultant cardiologist, physician and research director at The Royal Free NHS Foundation Trust, and Debbie Phillips, chief clinical information officer (CCIO) at Milton Keynes University Hospital NHS Foundation Trust. The pair explain how data and digital solutions can improve care pathways and clinical research that brings significant opportunity for improving health outcomes, and the need to ensure effective planning, staff and patient engagement and implementation strategies. The episode also highlights how Milton Keynes is designing enhanced clinical workflows that are underpinned with technology and use data for continuous improvement. Digital Health would like to thank its partner for this episode, Oracle Health. Panel: Ryan Irwin, lead client executive at Oracle Health Ameet Bakhai, consultant cardiologist, physician and research director at The Royal Free NHS Foundation Trust Debbie Phillips, CCIO at Milton Keynes University Hospital NHS Foundation Trust  

Ep. 13 Teaching the Future of Spine: Research, Motion Preservation, & Improving Care, Jeffrey A. Goldstein, MD   In this episode of The Spine Pod, co-hosts Courtney Schutze and Brady Riesgraf sit down with Dr. Jeffrey A. Goldstein, a globally recognized expert in orthopedic spine surgery and Director of the Spine Surgery Fellowship and Education programs at NYU Langone. With over 30 years of clinical and research experience, Dr. Goldstein is a staunch advocate for conservative, patient-first treatment plans. His patient-centered philosophy focuses on functional outcomes and prioritizing long-term health of every patient he treats.   Dr. Goldstein also discusses his commitment to ongoing innovation, especially in the area of motion preservation. Dedicated to advancing the field, he takes on a dual role as a pioneer in new technologies and a teacher, training residents and fellows in the latest techniques to carry his patient-first legacy forward. He has been a key leader across multiple clinical studies, including being a trainer for both cervical and lumbar artificial discs in the commercialization of ProDisc, as well as being the national PI for 3Spine's MOTUS Lumbar Total Joint Replacement IDE study. In addition to motion preservation, Dr. Goldstein continues to drive patient-care forward through the use of supplementary emerging technologies, including minimally invasive surgery (MIS) and robotics.   In this episode, listeners will learn about: The history of how spine care has changed over the past 30 years The entire function spinal unit, and the role of the facets and the disc in the mobility and stability of the spine How motion preserving technologies are becoming mainstream options for treating leg and/or back pain in the correctly indicated patient The convergence of enabling technologies, and how MIS, robotics, and motion preserving implants are coming together to improve patient outcomes The importance of conservative care and exhausting non-operative treatment options prior to receiving spine surgery Where the future of spine care is headed and the newest technologies entering the spine market     Dr. Goldstein has been a leading surgeon across the spine industry for more than 20 years, being recognized as a top doctor in America by multiple institutions, including Castle Connolly, New York Magazine, Becker's, and Newsweek. Aside from being recognized by sources and peers, he has also been the past president of ISASS, one of the largest spine conferences in the world, and also holds the title of professor of both orthopedic and neurosurgery at the NYU Grossman School of Medicine. With his accolades in teaching, leadership, and innovation, Dr. Goldstein has had a remarkable impact across the spine community since his inception into medicine.   This episode explores how Dr. Goldstein's work has not only shaped his practice but also the broader field of spine surgery, primarily through his dedicated contributions to motion preservation and patient-centered innovations. Whether you're a provider, patient, or industry professional, this episode provides vast insights into the technologies improving patient outcomes and what's on the horizon for the future of spine surgery.   Learn more about Dr. Goldstein and NYU Langone Health: Website: https://www.spinesurgerydoctor.com/  LinkedIn: https://www.linkedin.com/in/jeffrey-a-goldstein-md-facs-faoa-917b5b7/     You can find The Spine Pod on all Podcast Streaming Platforms, including: YouTube: / @thespinepod Spotify: https://open.spotify.com/show/0DBzWfV... Apple Podcasts: https://podcasts.apple.com/us/podcast... Amazon Music: https://music.amazon.com/podcasts/98f... iHeart Radio: https://www.iheart.com/podcast/269-th...     Follow The Spine Pod on Facebook to learn more about the latest episodes and happenings in the world of motion preservation: https://www.facebook.com/profile.php?...    

In this episode, Dr. Stephanie Budge talks with Dr. Angela Byars-Winston about the TransCARE Collaborative that she leads and the Collaborative's work to improve care services for two-spirit, trans, and non-binary people. Budge is Professor and Director of Clinical Training in the Department of Counseling Psychology at the University of Wisconsin-Madison and she is also an IDS Affiliate.

This workshop, organized by ICS and ASCRS, will explore multidisciplinary approaches to bowel incontinence, covering diagnosis, conservative treatments, and invasive procedures. It includes discussions on pelvic floor disorders, obstetric anal sphincter injury (OASIS), and neuromodulation. Attendees will gain insights through case discussions on current management practices. Find out more at https://www.ics.org/2024/session/7666  Early registration for ICS 2024 Madrid is now open at www.ics.org/2024The ICS annual meeting is the must-attend, multidisciplinary event for clinical and research scientists interested in: Urology Urogynaecology Female and functional urology Gynaecology Bowel dysfunction Neurourology Pure and applied science Physiotherapy Nursing Geriatrics The ICS 2024 Madrid conference fosters collaboration between all disciplines involved in continence care.

In this episode, Karrie and Penny will discuss the importance of applying the latest and best research to caring for patients. They will also describe how Summa Health's Center for Clinical Inquiry is promoting and supporting staff in using the best evidence to improve patient care. Additionally, Summa Health has re-instituted the advanced practice registered nurse called the Clinical Nurse Specialist at the bedside.

https://coloradosun.com/events Today - we're going to hear from Colorado Sun Marketing & Events Specialist Kristina Pritchett about a recent event The Colorado Sun held.See omnystudio.com/listener for privacy information.

Prior to 2020, patients newly diagnosed with breast cancer at Atrium Health Wake Forest Baptist's Comprehensive Cancer Center experienced high variability in the number of days it took to see a breast cancer provider. Scheduling was decentralized across the departments and rarely could multiple visits be coordinated to occur on the same day, within the same location. Addressing this issue required a coordinated, multidisciplinary approach that involved engaging the cancer center leadership across 3 treatment departments—medical, radiation, and surgical oncology—administration, physicians, advanced practice providers (APPs), patient navigation, genetic counseling, scheduling, imaging, lab, and pathology. The primary goals of the initiative were to transform patient experience and improve timeliness to care for every newly diagnosed patient. Guest: Hunter Hayes, MBA Associate Principal The Chartis Group   “Being able to get patients seen quickly; being able to retain patients for their full cancer treatment is incredibly important…competition is growing and being able to keep those patients and keep their experience positive is critical.”   Read more in “Improving the Care of Patients Newly Diagnosed With Breast Cancer” coming in your Volume 38, Number 2, Oncology Issues.   Resources: Improving Cancer Care Teamwork: Five Patient-Centered Strategies to Strengthen Care Coordination Machine Learning and Predictive Analytics Solution Transforms Infusion Center Operations Location Technology Improves Efficiency, Safety & the Patient Experience Breast Care ACCESS Project

Prior to 2020, patients newly diagnosed with breast cancer at Atrium Health Wake Forest Baptist's Comprehensive Cancer Center experienced high variability in the number of days it took to see a breast cancer provider. Scheduling was decentralized across the departments and rarely could multiple visits be coordinated to occur on the same day, within the same location. Addressing this issue required a coordinated, multidisciplinary approach that involved engaging the cancer center leadership across 3 treatment departments—medical, radiation, and surgical oncology—administration, physicians, advanced practice providers (APPs), patient navigation, genetic counseling, scheduling, imaging, lab, and pathology. The primary goals of the initiative were to transform patient experience and improve timeliness to care for every newly diagnosed patient. Guest: Hunter Hayes, MBA Associate Principal  The Chartis Group    “Being able to get patients seen quickly; being able to retain patients for their full cancer treatment is incredibly important…competition is growing and being able to keep those patients and keep their experience positive is critical.”    Read more in “Improving the Care of Patients Newly Diagnosed With Breast Cancer” coming in your Volume 38, Number 2, Oncology Issues.   Resources: Improving Cancer Care Teamwork: Five Patient-Centered Strategies to Strengthen Care Coordination Machine Learning and Predictive Analytics Solution Transforms Infusion Center Operations Location Technology Improves Efficiency, Safety & the Patient Experience Breast Care ACCESS Project Oncology IssuesVolume 39, Issue 2 Apr 2024  

Join us for this special episode of Caring as Communities! Dr. Enrique Enguidanos joins  with Asia Brown, CBCS, and Chris Douglas, FindHelp.org, to discuss key challenges facing individuals in accessing critical resources and identify patient-centric solutions that improve access and maintain individual dignity. BONUS CONTENT: This episode includes key testimonials from patients with complex health needs about resource navigation and successful solutions! 

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. To DRE or not to DRE? This is the question and the main event in this episode. We have a fantastic interview with Amy Rylance, Head of Improving Care at Prostate Cancer UK, and Sam Merriel, GP and academic clinical lecturer, discussing their recent Clinical Practice paper in the BJGP: Is the digital rectal exam any good as a prostate cancer screening test? In other research, we have two papers with a common theme. Firstly, a paper in the BMJ looking at long-term outcomes after diagnosis with atrial fibrillation, and secondly, a paper in the BJGP examining the role of BNP testing as a marker for future cardiovascular disease in patients with a new diagnosis of hypertension. Both show that while these conditions make us think of stroke and MI, we also should be thinking about heart failure. ResourcesBJGP Clinical Practice paper on DRE for prostate cancer screeningProstate Cancer UK Patient Risk CheckerEuropean Urology Oncology Journal Performance of DRE in PCa ScreeningNEJM 2004 Prevalence of PCa in men with a PSA

On this episode of our award-winning podcast, we continue discussing the impact and benefits of the latest generation of single-use endoscopes, which promise a revolutionary role in surgery.   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal Performance Improvement Consulting Vizient Guest: Andrew Bruenderman, MHA Category Manager Surgical Services Vizient   Show Notes: [00:44] Circumstances calling for single-use scopes [03:19] Financial considerations [04:37] ROI possibilities [06:05] Environmental impact [07:17] Final thoughts to consider   Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Andrew's email: andrew.bruenderman@vizientinc.com Vizient TechWatch article on single-use ureteroscopes: Vizient TechWatch Medical Device Vol. 3 (Single-Use Ureteroscopes).pdf   Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify RSS Feed

The latest generation of single-use endoscopes promises a revolutionary role in surgery. On this episode of our award-winning podcast, we discuss the impact and benefits of single-use ureteroscopes.   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal Performance Improvement Consulting Vizient Guest: Andrew Bruenderman, MHA Category Manager Surgical Services Vizient   Show Notes: [01:48] Early models were lacking; new models are advanced and improved [02:49] Cross-contamination and adverse events from multiuse scopes [04:15] Safety approaches with single-use scopes [05:21] Wave of the future? [06:20] Shelf life of single-use ureteroscopes and associated efficiencies [07:37] Problems with early models may cause reluctance to use later models   Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Andrew's email: andrew.bruenderman@vizientinc.com Vizient TechWatch article on single-use ureteroscopes: Vizient TechWatch Medical Device Vol. 3 (Single-Use Ureteroscopes).pdf   Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify RSS Feed Subscribe Today! Apple Podcasts Spotify Google Podcasts Android

In this heartfelt episode, Jacqueline shares her personal journey of navigating a pregnancy after experiencing multiple losses, including miscarriages and the loss of her daughter Maren at 20 weeks. Recorded from a makeshift desk in her family room, she discusses the emotional and physical changes her family has undergone in preparing their home for their new daughter, who is arriving via surrogacy. Jacqueline candidly talks about the complexities of dealing with PTSD and mental health issues after loss, her experiences with the healthcare system, and the importance of support for women going through similar challenges. She aims to offer reassurance and solidarity to listeners who may be facing their own struggles with pregnancy after loss, highlighting the significance of recognizing and addressing mental health and grief.00:00 Welcome to My Makeshift Studio: A Glimpse into My Life00:18 The Journey of Room Transformations and Personal Loss01:29 Embracing Change: Office Spaces and Preparing for Our Daughter02:02 Channeling Nervous Energy: Home Projects and Nursery Dreams04:26 Facing PTSD and the Complexities of Pregnancy After Loss08:36 Navigating the Emotional Landscape of Surrogacy and Anticipation16:22 The Importance of Mental Health Awareness in Pregnancy and Loss21:58 Improving Care for Women Experiencing Miscarriage or Loss28:26 Final Thoughts and Resources for Support•  Join the Motherhood Intended Community•  Follow @motherhood_intended on Instagram•  Leave a review for the podcast• Apply to be a guest on the showStruggling to conceive? Download this *free* Month-by-Month Roadmap to Your Fertility Success to help you stay focused on your journey to baby.This episode is brought to you by History on the Rocks, the podcast that brings you the fascinating tales of lesser known history while you get ready for the weekend with your favorite drink in hand. Join Cody and Audrey as they uncork the stories that time forgot. From famous people like George Washington and his distillery, to pirate queens causing mayhem on the high seas, each episode is a journey through the ages with endless possibilities. Give History on the Rocks a follow on Facebook and Instagram to keep up with news about the latest episodes.Support the showIf you're interested in helping give the absolute greatest gift to deserving parents, learn more about becoming a surrogate (and earn up to $650 just for taking the first few simple steps!): share.conceiveabilities.com/hello12

Dive deeper into how Zen can elevate your adrenal health and overall serenity at https://www.mswnutrition.com/products/zen. Incorporate Zen into your life for a more harmonious and balanced approach to daily challenges. Now, let's explore how conventional medicine can evolve for the better.   Timestamps 00:00 START 02:31 Address Liver Health 11:16 Enhance Mental Well-being 18:04 Strategic Supplement Usage 24:44 Recognize Food as Medicine 30:46 Importance of Optimal Lab Ranges Show Notes Liver Health: A deep dive into the epidemic of fatty liver disease and its systemic oversight in current healthcare practices. Mental Well-being: A call to action for the healthcare industry to prioritize mental health as a cornerstone of overall health. Supplements with Medications: A push towards integrating supplements to counteract the nutrient depleting effects of common medications. Food as Medicine: Advocacy for leveraging nutrition as a primary tool for disease prevention and health maintenance. Optimal Lab Ranges: Encouraging a shift from reactive to proactive healthcare by focusing on maintaining lab values within optimal ranges, not just within conventional 'normal' limits.   References: - Fatty Liver Awareness: https://liverfoundation.org/resource-center/blog/1-in-4-americans-at-risk-for-fatty-liver-disease-but-many-remain-undiagnosed/ - Depression in America: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483000/ - Mytavin Nutrient Depletion Calculator: https://mytavin.com/ - ADA Community Health Guidelines: https://diabetesjournals.org/care/article/46/Supplement_1/S10/148045/1-Improving-Care-and-Promoting-Health-in   Episode Mentions: - Zen and Mitochondriac by MSW Nutrition: For deeper insights and to include these products in your wellness routine, explore further information and procure them to enhance your adrenal and mitochondrial health respectively. Visit www.mswnutrition.com - Yoga for Mental Health: Research and consider incorporating yoga into your wellness practices for its mental health benefits. - COQ10 and Statins: Investigate the relationship between statin use and COQ10 depletion; consider COQ10 supplementation if on statin therapy. - Turmeric for Pain Management: Look into turmeric's efficacy in managing pain as a natural alternative to ibuprofen. - Green Tea for Brain Health: Explore the benefits of green tea consumption for maintaining optimal brain health.   Reignite Your Adrenal Health with Zen by MSW Nutrition – Embrace the journey to adrenal harmony and systemic balance. Zen awaits to guide you through the storms of life to a place of calm and strength. Begin your journey at www.msw.com/zenhttps://www.mswnutrition.com/products/zen.  

What makes us tick? Join Shane Turner and the Abiomed transport team as they share the driving forces behind their dedication to training. From simplifying complex issues to empowering transport crews, Transport Talks is here to help you feel more confident and, ultimately, to buoy patient outcomes. Let Transport Talks be your companion as you focus on what truly matters: patient recovery and saving lives beyond the hospital walls.In this episode, hear from members of Abiomed's Critical Care Transport training team:Diana Draehn, RN, BSN, CFRN, LP, Dallas, TXJena Billig, BSN, RN, CCRN, CFRN, Denver, COCaleb Merrell, RN, BSN, CFRN, LP, Austin, TXShane Turner, RN, CFRN, NRP, FP-C, CMTE, Chattanooga, TNNPS-4297

In this sponsored episode, we welcome Patrick McGill, a family physician and executive vice president and chief transformation officer at Community Health Network.  Together, we explore the theme of improving care with AI-powered solutions. Patrick shares his journey in health care innovation and the role of technology, particularly AI, in addressing health care challenges. His passion for technology's transformative potential in health care is palpable, as he discusses the pivotal role AI plays in addressing complex health care challenges. Transitioning to clinical documentation, Patrick shares insights into how Community Health Network harnesses AI, particularly Nuance's DAX Copilot, to streamline administrative tasks and enhance patient care. Personal anecdotes highlight the tangible benefits DAX Copilot brings to Patrick's medical practice, illustrating its potential to revolutionize health care workflows. As the conversation progresses, Patrick addresses common concerns about AI adoption and reflects on the future of technology in health care. VISIT SPONSOR → https://nuance.com/kevin SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RATE AND REVIEW → https://www.kevinmd.com/rate FOLLOW ON INSTAGRAM → https://www.instagram.com/kevinphomd FOLLOW ON TIKTOK → https://www.tiktok.com/@kevinphomd

How can home health and hospice organizations apply data to provide better patient care? What if data-driven predictive modeling could define with a high degree of certainty that a patient was on the verge of hospitalization … or pinpoint when a patient would die?What do future opportunities look like as artificial intelligence and machine learning make predictive modeling even more accurate and able to adjust predictions in real time as risk factors change?In this episode, Elliott Wood – president and CEO of Medalogix – and Stan Massey discuss these impactful topics and more.With Medalogix since 2013, Elliott leads the company in providing data outcomes that empower home health and hospice to make better patient care decisions. Based in Nashville, Medalogix is dedicated to empowering individualized patient care with innovative, data-driven solutions that enable a shift to value-based care. Including previous roles at HealthStream Inc in Nashville and AirStrip Technology in San Antonio, Elliott holds over 15 years of healthcare technology experience.

CME credits: 1.25 Valid until: 22-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/equitable-health-for-all-improving-care-for-underserved-populations-and-their-unmet-needs/24183/ Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead to coma and death if left untreated. This curriculum aims to improve the referral process from the initial onset of HE to consultation with a hepatologist by increasing knowledge of available tools for the identification, diagnosis, and treatment of HE. Ultimately, this educational program is intended to help narrow the gap in care for the underserved HE population. Video education created for patients is available for this topic. Visit www.mymededge.com to “prescribe” education that helps patients and caregivers learn more about this condition.

The TeleSANE Program utilizes telemedicine to connect facility site clinicians to consultants specifically trained in caring for patients who have experienced a sexual assault.The program provides equipment, education, and guidance to providers across the state of Arkansas to support a standardized care of practice. The consultants can be brought into the room with the site nurse and the patient for as much or as little as needed via a provided telecart.The program connects the community resources and helps build bridges to create a multi-disciplinary approach to sexual assault care. Patients can expect an evidence-based, trauma-informed medical forensic exam, connections to resources, and after-care follow-up guidance.

Dr. Dolce shares about early detection, innovative treatments and how to tackle widespread challenges in neonatal seizure care.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Chip and Dr. Liz Fowler, Deputy Administrator of CMS and Director of the agency's Center forMedicare and Medicaid Innovation (CMMI), discuss CMMI's mission to improve healthoutcomes, overcome the obstacles to health equity, and reduce care costs. They look back onwhat CMMS has accomplished in its first 10 years, what we have learned from thisexperimentation, and the future of care and payment innovation.Topics they examine include: CMMI's successes over the last decade and what programs have resonated most. Controversial CBO report that says CMMI's programs have increased federal spending –not lowered it. Performance of CMMI bundled payments and rationale behind a new mandatory bundledpayment program. Goals of the newly announced state-based AHEAD model and how it will interact withother ACO and value-based care programs. Dealing with the challenges created by massive growth in Medicare Advantage. How CMMI is addressing the broad issue of health equity.MORE:Dr. Fowler has the unique role of leading an agency she helped create. From 2008-2010, she wasChief Health Counsel to Senate Finance Committee Chair, Senator Max Baucus (D-MT), whereshe played a critical role in developing the Senate version of the Affordable Care Act. Theframework for the CMMI was embedded in the law – so now, after several roles in the private

Since opening this year, Children's Tower is Richmond's new home for pediatric in-patient emergency and level 1 trauma care. Dr. Matt Schefft discusses how the Children's Tower is improving care for kids in Richmond and beyond.

Howie and Harlan are joined by Zhenqiu Lin, senior director of analytics at Yale's Center for Outcomes Research and Evaluation, to discuss how quality measures can make care more consistent and effective and improve outcomes for patients. Howie provides an update on research on repetitive head trauma among young football players; Harlan reports on new findings about the benefits of semaglutide for people with heart disease. Links: “Neuropathologic and Clinical Findings in Young Contact Sport Athletes Exposed to Repetitive Head Impacts” American Academy Of Pediatrics: “Tackling in Youth Football” “National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction” “Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States” “Quality Measure Public Reporting Is Associated with Improved Outcomes Following Hip and Knee Replacement” “Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial” “Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Logan Miller, founder of Precision Consulting Solutions, joins the show to talk about organ and tissue donation and how many are working to improve the care for families.  Learn more about Precision Consulting Solutions at https://forensicorganrecovery.com/ Today's show is sponsored by:  ASD Answering Service for Directors Indiana Donor Network

Medicine Is Failing Disabled Patients. Meet The Doctors Pushing For Change “More than sixty-one million Americans have disabilities, and increasing evidence documents that they experience health care disparities.” That's the conclusion of a series of studies, in which researchers pulled back the curtain on how doctors perceive disabled patients. A study from last year found that more than half of surveyed physicians do not feel fully confident that they can provide disabled and non-disabled patients the same level of care. And in another paper, some doctors went as far to say that if you have a disability then “I am not the doctor for you.” So how do we change that? Ira talks with two researchers, who are disabled themselves, about how the medical field needs to better serve the disabled community. He hears from Dr. Lisa Iezzoni, an author on those studies and a professor of medicine at Harvard Medical School, who is based at the Health Policy Research Center at Massachusetts General Hospital in Boston. Also joining Science Friday is Dr. Feranmi Okanlami, a physician and assistant professor at the University of Michigan Medical School, based in Ann Arbor, Michigan. To Stop Whale Strikes, Ships Were Asked to Slow Down. It Worked. The Santa Barbara Channel is like an underwater national park with marine mammals, seabirds, fish and even shipwrecks. Ocean currents from the north and south meet and mix here to create an ideal feeding grounds for marine life. “Just the other day I was flying over the channel and we counted over 40 humpback whales in a rather small region feeding on fish,” said Sean Hastings, the Policy Management and Information Officer for the Channel Islands Marine Sanctuary—part of the National Oceanic and Atmospheric Administration or NOAA. We met at the Santa Barbara Maritime Museum, close to his office, and sat in the museum's library which is filled with books that are different shades of blues and greens—the colors you'd expect books about the ocean to be. Hastings continues his story about a recent flight over the channel spotting all those whales. To read the rest, visit sciencefriday.com.   How The Transistor Transformed The World 75 years ago this month, research scientists working at Bell Labs first created, then unveiled to the world a new device—the point contact transistor. Some call it the greatest invention of the 20th century. That first transistor was a clunky looking thing, with two gold contacts on a plastic wedge pressed against a crystal of germanium. But that early device had a magical property: A voltage in one part of the device could control the flow of electrons in another part of the transistor. It could be a switch, or an amplifier. That device and the ones that followed and improved on it would become an essential part of modern life. From the first transistor radios to modern computers, hearing aids, and more, transistors are everywhere, in great numbers. An ordinary cell phone today likely has billions of transistors in it. In fact, the transistor has become so ubiquitous that one estimate puts the number of transistors on the planet as about three million per square foot. The three researchers credited with the invention of the transistor, William Shockley, John Bardeen, and Walter Brattain, went on to share the Nobel Prize in Physics—but they saw limited financial gain from their creation, and had a rocky personal relationship. Michael Riordan, a physicist, science historian, and coauthor of “Crystal Fire: The Invention of the Transistor and the Birth of the Information Age,” joins Ira to look back on the invention, the scientists who got credit for the device, and where transistor technology has gone since 1947. Transcripts for each segment will be available the week after the show airs on sciencefriday.com.